Press release
Malmö, December 2, 2020

Arjo acquires AirPal – a US company focused on
patient transfers
Arjo today announces the acquisition of AirPal, a privately owned US-based company
specializing in Air-Assisted Lateral Patient Transfer solutions. The deal will strengthen
Arjo’s Patient Handling portfolio and is expected to have a positive impact on earnings
per share from 2022 and onwards.
“By adding AirPal’s products to our sales force we are able to fast-track our position within AirAssisted Lateral Transfer solutions in the important US market. This adds further growthpotential to our Patient Handling business where we can now offer a more complete solution toour customers. With this acquisition, we strengthen our ability to support healthcare by reducing
caregiver injuries and thus eliminating cost,” says Joacim Lindoff, President & CEO of Arjo.
Healthcare has the highest proportion of work-related injuries of all professional groups (of nonfatal accidents). 50-60% of all global healthcare professionals are affected by muscular skeletal
disorders.* Lateral transfers and repositioning are the most commonly cited patient handlingtasks reported in healthcare, and when performed manually, jeopardizes both staff and patient
health. Using an air-assisted system, such as AirPal, provides a more effective solution tomitigate the physical efforts and injury risks associated with performing lateral transfers, inaddition enabling reduced caregiver injuries and healthcare costs.
AirPal is the inventors of and received the first patent for Air Assisted Lateral Patient Transfer
Devices and specializes in these devices that uses a cushion of air to facilitate lateral
movement of patients that aims to minimize the risk of injury to both patients and caregivers.
AirPal’s technology releases low-pressure air through perforated chambers in its TransferPad,
which is placed under the patient in the same manner as a bed sheet.
Today, the US market size for Air Assisted lateral transfers is estimated at approximately
160 MUSD, with an estimated annual growth of 5%**. Currently Arjo has a significant US patient
handling market share of approx. 20-25%** not including lateral transfers where Arjo
is underrepresented with a low single digit market share. By acquiring AirPal and leveraging theArjo sales infrastructure, existing customer contacts and contracts, Arjo sees opportunities togain significant market share within 2-3 years and over time reach a market share similar to thelevel in the overall patient handling business.
The acquisition is part of the Group’s long-term strategic focus towards driving healthieroutcomes for people facing mobility challenges, and will help advance Arjo’s agenda towards
increased profitable growth. The initial focus is on the US market, followed by UK and Australia.

The deal is an asset purchase agreement and involves an upfront payment and an earn-out tiedto performance in 2021 to 2023. The acquisition is expected to have a limited positive impact on
Arjo’s EPS during 2021 but will contribute positively to EPS development in 2022 andincreasingly so onwards as sales synergies materialize.
*American Nurses Association. Health and Safety Survey, 2011**Arjo’s estimates

About AirPalAirPal® was founded in 1982 and is a privately owned company specializing in air-assisted lateral patient transfer andpositioning technology. In 2019, net sales amounted to approx. 4,5 MUSD. AirPal’s solutions are currently offeredmainly on the US market. The company is based in North Wales (PA), USA.

For more information, please contact:
Kornelia Rasmussen
Executive Vice President, Marketing Communications & Public Relations
Tel: +46 (0)10 335 4810
Email: kornelia.rasmussen@arjo.com

Maria Nilsson
Investor Relations & Corporate Communications
Tel: +46 (0)10 335 4866
Email: maria.nilsson@arjo.com

This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The
information was submitted for publication, through the agency of the contact person set out above, at 19.30 CET onDecember 2, 2020.

About Arjo
Creating the best conditions for mobility is at the very core of a high-quality healthcare offering. Arjo’s products andsolutions for patient handling, hygiene, disinfection, diagnostics, prevention of pressure injuries and deep veinthrombosis, and our medical beds, are designed to promote mobility, safety and dignity in all care situations.
With 60 years of experience of improving the everyday lives of patients, residents and healthcare providers, sales of
SEK 8.9 billion in 2019 and a global workforce of slightly more than 6,000, Arjo is constantly reinforcing its commitment
to create healthier outcomes for people with reduced mobility